EyePoint Pharmaceuticals
EYPT
#5310
Rank
โ‚น127.61 B
Marketcap
โ‚น1,541
Share price
0.47%
Change (1 day)
105.29%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -โ‚น18.57 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น42.34 Million. In 2024 the company made an earning of -โ‚น12.45 Billion a decrease over its 2023 earnings that were of -โ‚น6.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น18.57 Billion49.16%
2024 -โ‚น12.45 Billion99.41%
2023 -โ‚น6.25 Billion-29.88%
2022 -โ‚น8.9 Billion87.2%
2021 -โ‚น4.76 Billion38.58%
2020 -โ‚น3.44 Billion-24.56%
2019 -โ‚น4.55 Billion
2017 -โ‚น2.08 Billion22.59%
2016 -โ‚น1.7 Billion-8.02%
2015 -โ‚น1.84 Billion-296.09%
2014 โ‚น0.93 B-174.02%
2013 -โ‚น1.27 Billion37.42%
2012 -โ‚น0.93 Billion-56.29%
2011 -โ‚น2.11 Billion-1062.38%
2010 โ‚น0.21 B-250.43%
2009 -โ‚น0.15 Billion-89.5%
2008 -โ‚น1.39 Billion
2005 -โ‚น0.86 Billion56.99%
2004 -โ‚น0.55 Billion73.7%
2003 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
โ‚น2.47 B-112.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-โ‚น0.2 Billion-98.99% Bahamas